ACE and COVID-19: In addition, COVID-19-mediated ACE-II downregulation shifts angiotensin I (AT-I) into the angiotensin converting enzyme/angiotensin II/angiotensin II type I receptor pathway (ACE/AT-II/AT-1R), thus increasing the activity of angiotensin II (AT-II).